256 studies found for:    "Mouth Neoplasms"
Show Display Options
Rank Status Study
21 Completed Smoking Status and Body Image in Oral Cancer Patients
Condition: Oral Cavity Cancer
Interventions: Behavioral: Questionnaire;   Behavioral: Interview
22 Recruiting Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care
Conditions: Lip and Oral Cavity Squamous Cell Carcinoma;   Oral Cavity Verrucous Carcinoma;   Stage 0 Lip and Oral Cavity Cancer;   Tongue Cancer
Interventions: Procedure: fluorescence imaging;   Procedure: biopsy;   Procedure: examination;   Procedure: Comparison of surgical margins by COE vs. DVFE
23 Not yet recruiting Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage
Conditions: Mouth Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: TPF group;   Procedure: surgery group;   Radiation: Post-operative radiotherapy
24 Not yet recruiting a Trial of TPF(Docetaxel, Cisplatin and 5-fluorouracil ) Induction Chemotherapy in OSCC at cN2 Stage
Conditions: Mouth Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: TPF induction chemotherapy;   Procedure: surgery;   Radiation: radiotherapy
25 Not yet recruiting GDF15 Based TPF Induction Chemotherapy for OSCC Patients
Conditions: Mouth Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: TPF induction chemotherapy;   Procedure: surgery group;   Radiation: Post-operative radiotherapy
26 Completed The Feasibility Study of Dual-Section Nasogastric Tube
Conditions: Stroke;   Mouth Neoplasms
Intervention: Device: two-piece nasogastric tube
27 Active, not recruiting GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer
Conditions: Neoplasms, Oral;   Mouth Neoplasms
Intervention: Drug: GSK1120212
28 Terminated Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Neoplasms;   Laryngeal Neoplasms;   Mouth Neoplasms;   Pharyngeal Neoplasms
Interventions: Drug: cetuximab;   Drug: cisplatin (associated to radiotherapy)
29 Completed Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
Conditions: Carcinoma, Squamous Cell;   Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Hypopharyngeal Neoplasms
Intervention:
30 Recruiting Vitamin D - Celecoxib Therapy
Condition: Mouth Neoplasms
Interventions: Drug: celecoxib;   Drug: 1,25-dihydroxyvitamin D3 + celecoxib;   Drug: 1,25-dihydroxyvitamin D3
31 Active, not recruiting F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Conditions: Mouth Neoplasms;   Oropharyngeal Neoplasms;   Laryngeal Neoplasms;   Head and Neck Neoplasms
Intervention: Drug: F-18 Fluorothymidine
32 Terminated Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Conditions: Advanced Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
33 Terminated Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck;   Carcinoma, Squamous Cell;   Neoplasms, Squamous Cell;   Head and Neck Neoplasms;   Mouth Neoplasms;   Head and Neck Cancer
Intervention: Drug: Proxinium
34 Completed Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
Conditions: Lip and Oral Cavity Cancer;   Oropharyngeal Cancer;   Stage 0 Lip and Oral Cavity Cancer;   Stage 0 Oropharyngeal Cancer;   Tongue Cancer
Interventions: Biological: Ad5CMV-p53 gene;   Other: laboratory biomarker analysis
35 Withdrawn ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
Conditions: Lip and Oral Cavity Cancer;   Head and Neck Cancer;   Oropharyngeal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: ONYX-015
36 Enrolling by invitation Assessment of Mandibular Bone Invasion With MRI Using SWIFT
Condition: Oral Cancer
Intervention:
37 Completed Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Conditions: Carcinoma, Squamous;   Head and Neck Cancer;   Oral Cancer;   Laryngeal Cancer;   Pharyngeal Cancer
Interventions: Drug: Bortezomib (Velcade, PS-341);   Drug: Cetuximab;   Drug: Cisplatin;   Procedure: Radiation Therapy
38 Active, not recruiting Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
39 Recruiting Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer
Conditions: Locally Advanced Malignant Neoplasm;   Oral Cancer;   Oropharyngeal Carcinoma;   Effects of Chemotherapy
Intervention: Drug: Neo-adjuvant Erbitux-based chemotherapy
40 Recruiting Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
Condition: Oral Cancer
Interventions: Procedure: Portable Spectroscopy System;   Procedure: Multispectral Digital Microscope;   Procedure: Fast Excitation-Emission Matrix System

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years